We are live on ! Find out more
RPTX

Repare Therapeutics

Delisted

RPTX was delisted on the 27th of January, 2026.

48 hedge funds and large institutions have $709M invested in Repare Therapeutics in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

65.73% more ownership

Funds ownership: 0%65.73% (+66%)

Holders
48
Holders Change
+48
Holders Change %
% of All Funds
0.98%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
48
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$106M +$110M +3,426,325 New
MAM
2
MPM Asset Management
Massachusetts
$93.2M +$96.4M +3,003,772 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$78.4M +$81.1M +2,527,453 New
CA
4
CHI Advisors
New York
$77.7M +$80.4M +2,503,408 New
MB
5
MPM BioImpact
Massachusetts
$74.1M +$76.7M +2,388,337 New
RG
6
Redmile Group
California
$74M +$76.6M +2,386,174 New
BI
7
BVF Inc
California
$60.3M +$62.4M +1,944,546 New
LGM
8
Logos Global Management
California
$20.3M +$21.4M +666,894 New
AG
9
Artal Group
Luxembourg
$18.6M +$19.3M +600,000 New
RCM
10
RA Capital Management
Massachusetts
$12.7M +$13.1M +409,000 New
Franklin Resources
11
Franklin Resources
California
$11.3M +$16.1M +502,241 New
CAM
12
Cormorant Asset Management
Massachusetts
$10.9M +$11.3M +352,795 New
RSCM
13
Rock Springs Capital Management
Maryland
$8.53M +$8.82M +274,815 New
SFM
14
Sphera Funds Management
Israel
$7.6M +$7.86M +245,000 New
RI
15
RTW Investments
New York
$6.98M +$7.22M +225,000 New
Millennium Management
16
Millennium Management
New York
$6.92M +$7.17M +223,244 New
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$5.81M +$6.01M +187,157 New
UBS AM
18
UBS AM
Illinois
$5.73M +$5.93M +184,734 New
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$4.68M +$4.84M +150,730 New
FCM
20
Farallon Capital Management
California
$4.65M +$4.82M +150,000 New
Wellington Management Group
21
Wellington Management Group
Massachusetts
$4.36M +$4.51M +140,505 New
MIM
22
Monashee Investment Management
Massachusetts
$1.86M +$1.93M +60,000 New
CCM
23
CAAS Capital Management
New York
$1.55M +$1.61M +50,000 New
EC
24
EcoR1 Capital
California
$1.55M +$1.61M +50,000 New
Norges Bank
25
Norges Bank
Norway
$1.55M +$1.61M +50,000 New

RPTX Hedge Fund Activity: Q2 2020 in Review

48 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q2 2020, worth a combined $709M.

Buyers outnumbered sellers: 48 funds opened new RPTX positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $110M.

  • 48 institutional investors held Repare Therapeutics (RPTX) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $709M of Repare Therapeutics stock for Q2 2020.
  • 48 funds opened new Repare Therapeutics positions in Q2 2020 and 0 closed out, a net change of +48 holders.
  • The largest Repare Therapeutics buyer in Q2 2020 was OrbiMed, an estimated $110M added.

Based on aggregated 13F filings for Q2 2020.